139 related articles for article (PubMed ID: 7912453)
1. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis.
Kunikane H; Abe S; Yamaguchi E; Aparicio JM; Wakisaka A; Yoshiki T; Kawakami Y
Thorax; 1994 Jun; 49(6):573-6. PubMed ID: 7912453
[TBL] [Abstract][Full Text] [Related]
2. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP.
Ishihara M; Inoko H; Suzuki K; Ono H; Hiraga Y; Ando H; Naruse T; Ishida T; Ohno S
Jpn J Ophthalmol; 1996; 40(4):540-3. PubMed ID: 9130059
[TBL] [Abstract][Full Text] [Related]
3. HLA serological and class II genotyping in sarcoidosis patients in Japan.
Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
[TBL] [Abstract][Full Text] [Related]
4. Association of class II DNA restriction fragments with responsiveness to Ambrosia artemisiifolia (short ragweed)-pollen allergen Amb a V in ragweed-allergic patients.
Zwollo P; Ansari AA; Marsh DG
J Allergy Clin Immunol; 1989 Jan; 83(1):45-54. PubMed ID: 2563269
[TBL] [Abstract][Full Text] [Related]
5. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.
Redford A; Magalong D; Onohara-Toyoda M; Tyan D; Riley WJ; Maclaren NK; Rotter JI; Toyoda H
Dis Markers; 1991; 9(5):257-63. PubMed ID: 1686750
[TBL] [Abstract][Full Text] [Related]
6. Role of HLA-DR antigens in Japanese patients with sarcoidosis.
Kunikane H; Abe S; Tsuneta Y; Nakayama T; Tajima Y; Misonou J; Wakisaka A; Aizawa M; Kawakami Y
Am Rev Respir Dis; 1987 Mar; 135(3):688-91. PubMed ID: 3826893
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of susceptibility genes in sarcoidosis].
Ishihara M; Ohno S; Ishida T; Kagiya M; Ando H; Inoko H
Nippon Ganka Gakkai Zasshi; 1994 Jan; 98(1):80-5. PubMed ID: 8109450
[TBL] [Abstract][Full Text] [Related]
8. Genetic influences on sarcoidosis.
Ishihara M; Ohno S
Eye (Lond); 1997; 11 ( Pt 2)():155-61. PubMed ID: 9349405
[TBL] [Abstract][Full Text] [Related]
9. Correlations between polymorphisms at the DNA and at the protein level of DRw52 haplotypes, revealed with a variety of techniques.
Termijtelen A; Gorski J; Robbins FM; Tanigaki N; Tosi R; Tilanus MG; Schroeijers WE; van Rood JJ
Hum Immunol; 1988 Jul; 22(3):171-8. PubMed ID: 2902052
[TBL] [Abstract][Full Text] [Related]
10. Molecular mapping of class II polymorphisms in the human major histocompatibility complex. I. DR beta.
Bell JI; Denney D; MacMurray A; Foster L; Watling D; McDevitt HO
J Immunol; 1987 Jul; 139(2):562-73. PubMed ID: 2885373
[TBL] [Abstract][Full Text] [Related]
11. Analysis of class II genes of the chicken MHC (B) by use of human DNA probes.
Andersson L; Lundberg C; Rask L; Gissel-Nielsen B; Simonsen M
Immunogenetics; 1987; 26(1-2):79-84. PubMed ID: 2886426
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of sarcoidosis in relation to HLA distribution and HLA-DRB3 genotyping by PCR-RFLP.
Ishihara M; Ishida T; Mizuki N; Inoko H; Ando H; Ohno S
Br J Ophthalmol; 1995 Apr; 79(4):322-5. PubMed ID: 7742275
[TBL] [Abstract][Full Text] [Related]
14. Identification of two subtypes of HLA-DR2 by Southern blot analysis.
Singal DP; Butler L; Lamontagne L
Tissue Antigens; 1986 Jul; 28(1):29-40. PubMed ID: 3018959
[TBL] [Abstract][Full Text] [Related]
15. Restriction fragment length polymorphisms and an HLA-DRw52-associated split.
Chatila M; Luyrink L; McEleney J; Spies T; Strominger JL; Glass DN
Hum Immunol; 1988 Feb; 21(2):89-97. PubMed ID: 2896651
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism in intron 6 of the LMP7 gene in Japanese and its association with sarcoidosis.
Ishihara M; Ohno S; Ishida T; Naruse T; Inoko H
Tissue Antigens; 1997 Dec; 50(6):650-3. PubMed ID: 9458120
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DR phenotypes and T-lymphocyte-receptor beta-chain-region RFLP with IDDM in Japanese.
Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Takatsuki K; Itatsu T; Saito H
Diabetes; 1988 Dec; 37(12):1633-6. PubMed ID: 2903835
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR and -DQ genotyping in anti-GBM disease.
Dunckley H; Chapman JR; Burke J; Charlesworth J; Hayes J; Haywood E; Hutchison B; Ibels L; Kalowski S; Kincaid-Smith P
Dis Markers; 1991; 9(5):249-56. PubMed ID: 1686749
[TBL] [Abstract][Full Text] [Related]
19. Determination of the HLA-DR profile of an HLA class II negative carcinoma cell line by restriction fragment length polymorphism (RFLP) analysis.
Paulsen G; Markussen G; Sollid L; Thorsby E
Tissue Antigens; 1987 Apr; 29(4):186-94. PubMed ID: 2887045
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR and DQ matching by DNA restriction fragment length polymorphism methods and the outcome of mixed lymphocyte reaction tests in unrelated bone marrow donor searches. The IMUST Study.
Howard MR; Brookes P; Bidwell JL; Bidwell EA; Clay TM; Evans JL; Hows JM; Bradley BA
Bone Marrow Transplant; 1992 Mar; 9(3):161-6. PubMed ID: 1354994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
